Acquisitions (Tables)

9 Months Ended

Sep. 30, 2014

Fair Value Of Total Consideration Transferred And Major Class Of Consideration

The acquisition date fair value of the total consideration transferred and acquisition date fair value of each major class of consideration for the acquisitions completed in the nine months ended September 30, 2014 and 2013, including post acquisition date adjustments recorded to purchase price allocations, are as follows (in thousands):



	Nine Months Ended September 30,
	2014						2013
				Individual			Individual
	Sheridan ⁽¹⁾			Acquisitions			Acquisitions
Accounts receivable	$	129,234		$	1,023		$	3,082
Other current assets	110,335			892			1,801
Property and equipment	14,258			2,481			5,357
Goodwill	1,512,663			44,374			91,545
Intangible assets	1,200,028			—			—
Other long-term assets	50,533			—			—
Accounts payable	(5,776		)	(2,341		)	(1,482		)
Other accrued liabilities	(117,159		)	(527		)	(416		)
Deferred income taxes	(411,881		)	—			—
Other long-term liabilities	(72,623		)	—			—
Long-term debt	—			(214		)	(2,561		)
Total fair value	2,409,612			45,688			97,326
Less: Fair value attributable to noncontrolling interests	23,361			21,251			38,123
Acquisition date fair value of total consideration transferred	$	2,386,251		$	24,437		$	59,203


(1)	The allocation of fair value of acquired assets and liabilities associated with the Sheridan acquisition is preliminary at September 30, 2014.

Revenues And Net Earnings Associated With Acquisitions

Revenues and net earnings included in the nine months ended September 30, 2014 and 2013 associated with completed acquisitions are as follows (in thousands):



	Nine Months Ended September 30,
	2014				2013
			Individual		Individual
	Sheridan		Acquisitions		Acquisitions
Net revenues	$	226,545	$	9,925	$	6,422

Net earnings	19,684		2,293		1,922
Less: Net earnings attributable to noncontrolling interests	164		1,412		1,081
Net earnings attributable to AmSurg Corp. common shareholders	$	19,520	$	881	$	841

Consolidated Pro Forma Results Of Acquisition

The unaudited consolidated pro forma results for the nine months ended September 30, 2014 and 2013, assuming all acquisitions completed prior to September 30, 2014 had been consummated on January 1, 2013, all 2013 acquisitions had been consummated on January 1, 2012 and exclude nonrecurring items, such as transaction costs and debt extinguishment costs, that are directly attributable to the acquisitions and that are not expected to have a continuing impact, are as follows (in thousands):



	Nine Months Ended September 30,
	2014		2013
Revenues	$	1,617,342	$	1,611,110
Net earnings	204,675		195,624
Amounts attributable to AmSurg Corp. shareholders:
Net earnings	62,914		51,613
Net earnings per common share:
Basic	$	1.20	$	0.96
Diluted	$	1.18	$	0.95